Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Technological Advances Linked to Medical Misadventures

Simon M. Helfgott, MD  |  April 15, 2016

For keen students of American politics, the unending intrigue of the 2016 presidential race has been riveting. With an assemblage of aspiring candidates that, at its start, included a bevy of U.S. senators and former governors, a media-savvy real estate mogul, a renowned Hopkins neurosurgeon and an ophthalmologist, political junkies among us have feasted on…

Filed under:OpinionPractice SupportQuality Assurance/ImprovementRheuminationsSpeak Out RheumTechnology Tagged with:dataEHRelectronic health recordmedical errorphysicianPractice ManagementQualityrheumatologistTechnology

Practicing Mindfulness Can Help Alter Patients’ Experience With Chronic Rheumatic Diseases

Practicing Mindfulness Can Help Alter Patients’ Experience with Chronic Rheumatic Diseases

C. Ronald MacKenzie, MD  |  April 15, 2016

Mindfulness is a mental state achieved by focusing one’s awareness on the present moment, while acknowledging and non-judgmentally accepting one’s feelings, thoughts and bodily sensations. Known in Sanskrit as smrti, meaning “to remember,” in Pali, the language of early Buddhist scriptures, it is recognized by the word sati (mindfulness).1 Derived from ancient meditative Buddhist disciplines,…

Filed under:ConditionsPain SyndromesPractice SupportQuality Assurance/Improvement Tagged with:FibromyalgiaManagementmindfulnessPainpatient careRheumatic DiseaseRheumatoid arthritisStress

The ACR Joins Call for Dedicated Arthritis Research Funding to Help Veterans

From the College  |  April 15, 2016

Arthritis is the primary cause of disability among U.S. military veterans and the second most common reason for medical discharge from the U.S. Army. One in three veterans is diagnosed with arthritis, compared with one in five members of the general U.S. population. It is important to keep in mind that these statistics reflect only…

Filed under:ConditionsFrom the CollegeLegislation & AdvocacyResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)ArthritisDepartment of Defense (DoD)FundingMilitarypatient careResearchveterans

The ACR, ARHP Develop National Research Agenda for 2016–2020

From the College  |  April 15, 2016

Since 2005, the ACR’s Committee on Research has been responsible for advancing the research goals of the organization and providing leadership in research and research training in rheumatology via the ACR’s Research Agenda. The ACR Research Agenda is designed to address critical areas of research in rheumatic diseases, including the need for new technology, new…

Filed under:From the CollegeResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)Research

Tips for Selecting Best Job Candidates to Fill Positions, Avoid Turnover

Karen Appold  |  April 14, 2016

As much as 80% of employee turnover can be attributed to bad hiring decisions, the Harvard Business Review reported.1 And turnover costs are high—one report estimated them to be 100–300% of the base salary of a replaced employee (with 150% commonly cited).2 Given this, the importance of hiring the right employees can’t be underestimated. So…

Filed under:Practice Support Tagged with:candidateemployeejobPractice Managementresumerheumatologistturnover

Carpal Tunnel Syndrome: Is Post-Surgical Rehabilitation Helpful?

Lara C. Pullen, PhD  |  April 11, 2016

A recent research review compared the results of various studies on rehabilitation treatments, including immobilization, exercise and cold therapy, for patients with carpal tunnel syndrome after surgery. The authors concluded that little evidence supports the effectiveness of rehabilitation techniques, and many of the studies reviewed have similar limitations…

Filed under:Conditions Tagged with:Carpal Tunnel SyndromeExercisePhysical Therapysurgery

Remicade Antibodies Cross-React to Biosimilars

Lorraine L. Janeczko  |  April 6, 2016

NEW YORK (Reuters Health)—Patients with antibodies to infliximab in Remicade should not be switched to biosimilars, researchers warn. “(The) antibodies will cross-react with the new biosimilar drug, potentially reducing clinical response,” Dr. Daniel Nagore, director of research and development at Progenika Biopharma in Derio, Spain, told Reuters Health by email. “The study highlights the importance…

Filed under:Biologics/DMARDsDrug Updates Tagged with:FDAFood and Drug Administrationinfliximabinfliximab-dyyb

Biosimilar Drugs Could Save Up to $110 Billion by 2020

Reuters Staff  |  March 30, 2016

LONDON (Reuters)—Lower-cost copies of complex biotech drugs, known as biosimilars, could save the U.S. and Europe’s five top markets as much as 98 billion euros ($110 billion) by 2020, a new analysis showed on Tuesday. Realizing those savings, however, depends on effective doctor education and healthcare providers adopting smart market access strategies, the report by…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabBiosimilarscostshealthcare costTreatment costs

Fibromyalgia & Bipolar Spectrum Disorder: A Shared Pathophysiology May Lead to Better Drug Targets

Lara C. Pullen, PhD  |  March 21, 2016

Patients suffering from fibromyalgia and those suffering from bipolar spectrum disorder experience similar symptoms. Research suggests that these diseases may share a pathophysiological process, particularly a similar impairment in the prefrontal-limbic networks of the brain. A new editorial addresses how a better understanding of the potential shared biological underpinning of these diseases could result in unique drug targets…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:Bipolar Spectrum DisorderFibromyalgiaMental HealthPain

U.S. Agency Issues New Guidelines to Limit Chronic Use of Opioids

Ransdell Pierson  |  March 18, 2016

(Reuters)—Addressing a growing “epidemic” of opioid overdoses and abuse of the prescribed painkillers in the U.S., the Centers for Disease Control and Prevention on Tuesday released voluntary guidelines that instruct primary care doctors to sharply deter use of the medicines for chronic pain. “Overprescribing opioids, largely for chronic pain, is a key driver of America’s…

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:Centers for Disease Control and PreventionChronic painGuidelinesOpioids

  • « Previous Page
  • 1
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • 243
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences